Document:

Exhibit
10.4

 

THIS
INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR THE ISRAELI SECURITIES LAW 5728 – 1968, AS AMENDED, OR ANY STATE OR FOREIGN SECURITIES LAWS. THESE SECURITIES
MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES
LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

 

Parazero
Technologies Ltd.

 

SAFE

 

(Simple
Agreement for Future Equity)

 

THIS
CERTIFIES THAT in exchange for the payment by (the “Investor”) of $[] (the “Purchase
Amount”) on [], 2022, to Parazero Technologies Ltd., an Israeli private company (P.C.N. 514932821) (the “Company”),
the Company hereby issues to the Investor the right to certain shares of the Company, subject to the terms set forth below in this Simple
Agreement for Future Equity (this “SAFE”). Concurrently with the execution of this SAFE, the Company enters into similar
SAFEs (collectively, the “Additional SAFEs”); provided that the aggregate purchase amount of the Additional
SAFEs together with the Purchase Amount under this SAFE shall not exceed US$2,500,000 and based on the allocation listed on Annex
A.

 

1. Events.

 

1.1 Automatic
Conversion in a Qualified Equity Financing. If there is a Qualified Equity Financing before the expiration or termination of this
SAFE, this SAFE will automatically convert into the number of SAFE Shares equal to the Purchase Amount, divided by the Discount Price,
rounded up to the nearest whole number. In connection with the automatic conversion of this SAFE into SAFE Shares, each Investor will,
at the request of the Company in its sole discretion, execute and deliver to the Company all transaction documents related to the Qualified
Equity Financing; provided, that such documents (i) are the same documents to be entered into with the purchasers in the Qualified
Equity Financing, with appropriate variations for the SAFE Shares, as applicable, and (ii) have customary exceptions to any drag-along
applicable to the Investor, including (without limitation) limited representations, warranties, liability and indemnification obligations
for the Investor.

 

1.2 Optional
Conversion in a Non-Qualified Financing. If there is an Equity Financing by the Company which does not qualify as a Qualified Equity
Financing (“Non-Qualified Financing”), the outstanding Purchase Amount may be converted, at the written request of
the Investor made at Investor’s sole discretion within 30 days from the receipt of a written notice from the Company setting forth
the terms and conditions of such Non-Qualified Financing, into Safe Shares equal to the Purchase Amount divided by the Discount Price,
provided, that such documents are the same documents to be entered into with the investor of the Non-Qualified Financing, with
appropriate variations for the SAFE Shares if applicable as aforementioned. Each Investor will, at the request of the Company in its
sole discretion, execute and deliver to the Company all transaction documents related to the Non-Qualified Financing; provided, that
such documents are the same documents to be entered into with the purchasers in the Non-Qualified Financing, with appropriate variations
for the SAFE Shares, as applicable.

 

     

     

    

 

1.3 Liquidity
Event. If a Liquidity Event is consummated before the expiration or termination of this SAFE, this SAFE will automatically receive
immediately prior to, or concurrent with, the consummation of such Liquidity Event, from the Company, a number of Ordinary Shares, equal
to the Purchase Amount divided by the Liquidity Price. Each Investor will, at the request of the Company, in its sole discretion, execute
and deliver to the Company all documents related to the Liquidity Event, including lock-up undertakings, as may be applicable, provided
that such documents are the same documents to be entered into with the other shareholders of the Company with appropriate variations
for the SAFE Shares as applicable.

 

1.4 Public
Offering. If an Initial Public Offering is consummated before the expiration or termination of this SAFE, this SAFE will automatically
convert, immediately prior to and subject to, the unconditional closing of such Initial Public Offering, into a number of Ordinary Shares,
equal to the Purchase Amount divided by the price per share in the Initial Public Offering, discounted by the Discount Rate. Each Investor
will, at the request of the Company and\or the underwriter, execute and deliver to the Company all documents related to the Initial Public
Offering, as may be applicable, provided that such documents are the same documents to be entered into with the other shareholders
of the Company with appropriate variations for the SAFE Shares as applicable.

 

1.5 Mandatory
Conversion upon Drop Date. If the Purchase Amount has not been converted prior to July 31, 2023 (the “Drop Date”),
then on such Drop Date, this SAFE shall be automatically converted into such number of the most senior class of Equity Shares of the
Company then outstanding, equal to, the Purchase Amount, divided by the lowest price per share actually paid to the Company for such
most senior class of Equity Shares of the Company then outstanding in an investment transaction by a third party on or after 1.1.2022,
discounted by the Discount Rate, rounded up to the nearest whole number, and if such investment transaction shall not have occurred,
then this SAFE shall be automatically converted into such number of the most senior class of Equity Shares of the Company then outstanding,
equal to, the Purchase Amount, divided by $3.313 AUD (subject to any customary adjustments for share splits and consolidations). The
closing of such mandatory conversion for the Investor shall occur within 14 days of the Drop Date.

 

1.6 Dissolution
Event. If there is a Dissolution Event before this instrument expires or terminates, following payment of all senior debt, the Company
will pay an amount equal to the Purchase Amount, immediately prior to, or concurrent with, the consummation of the Dissolution Event.
The Investor’s right to receive its Purchase Amount is (i) senior and in preference to any Distribution of any of the assets of
the Company to holders of outstanding Share Capital by reason of their ownership thereof and (ii) on par with payments for other SAFEs.
If the applicable Proceeds or assets of the Company legally available for distribution to the Investor herein or under the Additional
SAFEs (the “Dissolving Investors”), as determined in good faith by the Company’s board of directors, are insufficient
to permit the payment to the Dissolving Investors of their respective Purchase Amounts, then the entire assets of the Company legally
available for distribution will be distributed with equal priority and pro rata among the Dissolving Investors in proportion to
the Purchase Amounts they would otherwise be entitled to receive pursuant to this Section 1.6.

 

    2

     

    

 

1.7 Termination.
This SAFE will automatically expire and terminate upon the earliest to occur of either: (i) the issuance of SAFE Shares to the Investors
pursuant to Section 1.1, Section 1.2, Section 1.3, Section 1.4, or Section 1.5, or (ii) the payment, or setting
aside for payment, of amounts due the Investors pursuant to Section 1.6.

 

2. Definitions

 

2.1 “Change
of Control” means (i) a transaction or series of related transactions as a result of which more than 50% of the shares of the
Company are transferred to any third party (ii) any reorganization, merger, consolidation, recapitalization or similar event of the Company
other than a single transaction or a series of related transactions as a result of which the shareholders of the Company holding a majority
of the voting securities immediately prior to such transaction or series of related transactions retain, immediately after such transaction
or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of
the Company or such other surviving entity (iii) a sale, lease grant of an exclusive license or other disposition of all or substantially
all of the assets of the Company, or (iv) a sale of all or substantially all of the shares of the Company.

 

2.2 “Discount
Price” means the lowest price per SAFE Share sold in the Equity Financing discounted by the Discount Rate.

 

2.3 “Discount
Rate” means a 20% discount; however, in the event of an Initial Public Offering the Discount Rate shall be 25%.

 

2.4 “Distribution”
means the transfer to holders of Share Capital by reason of their ownership thereof of cash or other property without consideration
whether by way of dividend or otherwise, other than dividends on Ordinary Shares payable in Ordinary Shares, or the purchase or redemption
of Share Capital by the Company or its subsidiaries for cash or property other than: (i) repurchases of Ordinary Shares held by employees,
officers, directors or consultants of the Company or its subsidiaries pursuant to an agreement providing, as applicable, a right of first
refusal or a right to repurchase shares upon termination of such service provider’s employment or services; or (ii) repurchases
of Share Capital in connection with the settlement of disputes with any shareholder.

 

2.5 “Dissolution
Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors,
or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary
or involuntary.

 

2.6 “Equity
Financing” means a Qualified Equity Financing or a Non-Qualified Financing.

 

2.7 “Initial
Public Offering” means the closing of the Company’s first firm commitment underwritten initial public offering of Ordinary
Shares pursuant to a registration statement filed under the Securities Act or of other similar securities law of another jurisdiction.
For the sake of this Agreement, the term Public Offering shall also mean a reverse merger or an investment in a Capital Pool Company
(CPC).

 

    3

     

    

 

2.8 “Liquidity
Event” means a Change of Control.

 

2.9 “Liquidity
Price” means the price per share of the Ordinary Shares sold or registered in a Liquidity Event multiplied by the Discount
Rate or the fair market value of the Ordinary Shares at the Liquidity Event multiplied by the Discount Rate.

 

2.10 “Ordinary
Shares” means the ordinary shares of the Company.

 

2.11 “Proceeds”
means cash and other assets (including, without limitation, consideration in shares) that are proceeds from the Liquidity Event or the
Dissolution Event, as applicable, and legally available for distribution.

 

2.12 “Qualified
Equity Financing” means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant
to which the Company issues and sells shares at a fixed pre-money valuation, in which the aggregate proceeds to the Company are at least
US $3,000,000 (excluding the SAFEs hereunder).

 

2.13 “SAFEs”
means instruments containing future right to shares of the Company’s Share Capital, similar in form and content to this SAFE, purchased
by investor for the purpose of funding the Company’s business operations.

 

2.14 “SAFE
Shares” means the then most senior shares issued to the Investor in any Equity Financing, having the identical rights, privileges,
preferences and restrictions as the Equity Shares, including, without limitation, liquidation preference, anti-dilution protection, registration
rights, preemptive rights, right of first refusal, voting and veto rights, or other rights, pro-rata to the respective amounts of investment,
and the Investor shall otherwise be deemed one of the investors in such Equity Financing for all purposes (including with respect to
any other securities, warrants or other or other rights granted to the investor, other than with respect to (if and to the extent applicable):
(i) the per share liquidation preference and the initial conversion price for purposes of price-based anti-dilution protection, which
will equal the Discount Price; (ii) the basis for any dividend rights, which will be based on the Discount Price; and (iii) any individual
rights granted to certain investors based on the size of their investment or number of shares they will receive (subject to the same
minimum holding requirements if applicable). The right to receive SAFE Shares shall also include the right to receive any components
of a unit offered to the investors in such Equity Financing, including for example, warrants or other convertible instruments granted
to the investors in the Equity Financing, if granted. In addition to the transfer restrictions set forth in Section 5 below, in no event
shall warrants issued to an Investor upon the conversion of a SAFE be tradable warrants nor carry any registration rights. For avoidance
of doubt it is hereby clarified that if the Company has no preferred class of shares in its share capital the SAFE Shares shall mean
Ordinary Shares of the Company.

 

2.15 “Equity
Shares” means the shares of a series of Shares issued to the investor investing new money in the Company in connection with
the initial closing of the Equity Financing.

 

    4

     

    

 

2.16 “Share
Capital” means the share capital of the Company, including, without limitation, Ordinary Shares and, if applicable, preferred
Shares of the Company.

 

2.17 “Subsequent
Convertible Securities” means convertible securities that the Company may issue after the issuance of this instrument with
the principal purpose of raising capital, including but not limited to, other SAFEs, convertible debt instruments and other convertible
securities. Subsequent Convertible Securities excludes options issued pursuant to any equity incentive or similar plan of the Company.

 

3. Company
Representations.

 

3.1 The
Company is a corporation duly organized and validly existing under the laws of the state of Israel, and has the power and authority to
own, lease and operate its properties and carry on its business as now conducted.

 

3.2 The
execution, delivery and performance by the Company of this SAFE is within the power of the Company and has been duly authorized by all
necessary actions on the part of the Company. This SAFE constitutes a legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally and general principles of equity. The Company is not in violation
of (i) its current articles of association, (ii) any material statute, rule or regulation applicable to the Company or (iii) any material
indenture or contract to which the Company is a party or by which it is bound, where, in each case, such violation or default, individually,
or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

 

3.3 The
performance and consummation of the transactions contemplated by this SAFE do not and will not: (i) violate any material judgment, statute,
rule or regulation applicable to the Company; (ii) result in the acceleration of any material indenture or contract to which the Company
is a party or by which it is bound; or (iii) result in the creation or imposition of any lien on any property, asset or revenue of the
Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its
business or operations.

 

3.4 No
consents or approvals are required in connection with the performance of this SAFE, other than: (i) the Company’s corporate approvals;
(ii) necessary corporate approvals for the authorization of the Company’s Share Capital issuable pursuant to Section 1.

 

3.5 To
its knowledge and without conducting any specific investigation, the Company owns or possesses (or can obtain on commercially reasonable
terms) sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information,
processes and other intellectual property rights necessary for its business as now conducted, without any conflict with, or infringement
of the rights of, others.

 

4. Investor
Representations.

 

4.1 The
Investor has full legal capacity, power and authority to execute and deliver this SAFE and to perform its obligations hereunder. This
SAFE constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy,
insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general
principles of equity.

 

    5

     

    

 

4.2 The
Investor had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions of the
offering of the Share Capital with the Company’s management and to consult with its advisors with respect to such matters.

 

4.3 The
Investor understands that no public market now exists for the Share Capital, and that the Company has made no assurances that a public
market will ever exist for the Share Capital.

 

4.4 The
Investor is either (i) an “accredited Investor” as such term is defined in Rule 501(a) of Regulation D under the Securities
Act; or (ii) not a U.S. person within the meaning of Rule 902 of Regulation S under the Securities Act. The Investor is purchasing this
security instrument for his, her or its own account for investment, not as a nominee or agent, and not with a view to, or for resale
in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or
otherwise distributing the same. The Investor has such knowledge and experience in financial and business matters that the Investor is
capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing
the Investor’s financial condition, and is able to bear the economic risk of such investment for an indefinite period of time.

 

4.5 In
the event of an Initial Public Offering, if required by the underwriters, the Investor will enter into a lock-up agreement in respect
of SAFE Shares. The Investor appoints the Company as its agent and attorney-in-fact to execute, on the Investor’s behalf, any such
lock-up agreement.

 

5. Transfer
Restrictions

 

5.1 The
Parties further acknowledge and are aware that the SAFE Shares issuable hereby may only be disposed of in compliance with respective
U.S. state and U.S. federal securities laws. In connection with any transfer of the SAFE Shares other than pursuant to an effective registration
statement, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor
and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to
the effect that such transfer does not require registration of such transferred Safe Shares under the Securities Act.

 

5.2 The
Investor agrees to the imprinting, so long as is required by this Section 5, of a legend on any of the SAFE Shares in the following form:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS AS EVIDENCED
BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

    6

     

    

 

5.3 Certificates
evidencing the SAFE Shares shall not contain any legend (including the legend set forth in 5.2 hereof): (i) while a registration statement
covering the resale of such security is effective under the Securities Act, (ii) following any sale of such SAFE Shares pursuant to Rule
144, (iii) if SAFE Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the
current public information required under Rule 144 as to such SAFE Shares and without volume or manner-of-sale restrictions, or (iv)
if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the transfer agent of the Company
promptly after the respective effective date of the transfer if required by the transfer agent to effect the removal of the legend hereunder.

 

5.4 The
Investor agrees with the Company that the Investor will sell any SAFE Shares pursuant to either the registration requirements of the
Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if SAFE Shares are
sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein, and
acknowledges that the removal of the restrictive legend from certificates representing the Safe Shares as set forth in this
Section 5 is predicated upon the Company’s reliance upon this understanding.

 

6. Preferable
Amendment of Terms.

 

If
the Company amends the terms of this SAFE to accommodate additional investors’ terms or issues any Subsequent Convertible Securities
with terms more favorable of this SAFE prior to termination of this instrument, the Company will promptly provide the Investor with written
notice thereof, together with a copy of all documentation relating to such amendment or Subsequent Convertible Securities. In the event
an Investor determines that the amended terms of this SAFE or terms of the Subsequent Convertible Securities are preferable to the terms
of this instrument, such Investor will notify the Company in writing. Promptly after receipt of such written notice from the Investor,
the Company agrees to amend and restate this instrument to be identical to the instrument(s) evidencing the amendment or Subsequent Convertible
Securities.

 

7. Tax;
Expenses.

 

Each
party shall bear its own expenses and taxes arising hereof. Any taxes, levies, charges and other duties or other amounts, that are levied
or due in connection with the transfer of the Investor’s portion of the Purchase Amount and/or the issuance of any shares to the
Investor, shall be borne by the Investor.

 

8. Miscellaneous.

 

8.1 Any
provision of this instrument may be amended, waived or modified only upon the written consent of the Company and the Investor.

 

    7

     

    

 

8.2 Any
notice required or permitted by this SAFE will be deemed sufficient when delivered personally or by overnight courier or sent by email
to the relevant address listed on the signature page, or 7 days after being deposited in the mail as certified or registered mail with
postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently modified
by written notice.

 

8.3 The
Investor is not entitled, as holder of this SAFE, to vote or receive dividends or be deemed a holder of Share Capital for any purpose,
nor will anything in this SAFE be construed to confer on the Investor, as such, any rights of a shareholder of the Company or rights
to vote for the election of directors or on any matter submitted to shareholders at any meeting thereof, or to give or withhold consent
to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise until shares have been issued
on the terms described herein.

 

8.4 Neither
this SAFE nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the prior written
consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned without the Company’s
consent by the Investor, to any other entity who directly or indirectly, controls, is controlled by or is under common control with such
Investor, including, without limitation, any general partner, managing member, officer or director of such Investor, or any venture capital
fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management
company with, such Investor, and provided, however, that the Company may assign this SAFE in whole, without the consent of the
Investor, in connection with a reincorporation to change the Company’s domicile.

 

8.5 In
the event any one or more of the provisions of this SAFE is for any reason held to be invalid, illegal or unenforceable, in whole or
in part or in any respect, or in the event that any one or more of the provisions of this SAFE operate or would prospectively operate
to invalidate this SAFE, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other
provision of this SAFE and the remaining provisions of this SAFE will remain operative and in full force and effect and will not be affected,
prejudiced, or disturbed thereby.

 

8.6 All
rights and obligations hereunder will be governed exclusively by the laws of the State of Israel, without regard to the conflicts of
law provisions of such jurisdiction and the competent courts of the city of Tel Aviv, Israel shall have exclusive jurisdiction with respect
to all matters arising out of or related to this instrument.

 

8.7 This
SAFE may be executed in any number of counterparts and at one or more times, each of which containing the signature of any of each of
the parties shall be deemed an original but all of which together shall constitute one and the same instrument.

 

[Next
Page - Signature Page]

 

    8

     

    

 

[Signature
Page - Parazero Technologies Ltd. – 2022 SAFE]

 

IN
WITNESS WHEREOF, the undersigned have caused this instrument to be duly executed and delivered.

 

COMPANY:

 

Parazero
Technologies Ltd.

 

	By:
	 	 
	Name:	 	 
	Title:	 	 

 

INVESTOR:

 

[Name
of Investor]

 

	By:
	 	 
	Name:	 	 
	Title:	 	 

 

    9

     

    

 

Annex
A

 

	 

    Name
    of Shareholder
	Address	Purchase
    Amount (ILS)	Signature
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

 

    10

     

    

 

Parazero
Bank account details-

 

	BANK
NAME
	BANK
    LEUMI LE ISRAEL B.M.
	BANK
    Number	10
	BRANCH
    NAME & Number	LEUMITECH
    BUSINESS CENTER 864
	Account
    Number	19760004
	BRANCH
    ADDRESS	11
    GALGALEY HAPLADA ST., HERZELIYA
	SWIFT
    (BIC) CODE	LUMIILITXXX
	ROUTING
    NO.	IL010864//
	IBAN
    NO.	IL380108640000019760004
	BENEFICIARY
    NAME	PARAZERO
    TECHNOLOGIES LTD

 

 

11Exhibit 10.5

 

LOAN
CONVERSION AGREEMENT

 

This Loan Conversion Agreement
(this “Agreement”) is entered into as of January 28, 2022 (the “Effective Date”), by and between
ParaZero Technologies Ltd., an Israeli company (the “Company”); and Delta Drone International Ltd., an Australian company
(“Parent”).

 

WHEREAS the Company has
an outstanding debt to Parent in a total amount of AUD 10,401,411 (the “Conversion Amount”); and

 

WHEREAS
Parent desires and agrees to convert the Conversion Amount into new share capital of the Company;

 

NOW,
THEREFORE, in consideration of the terms and conditions set forth herein, the Parties hereto
agree as follows:

 

1.
Interpretation

 

The headings of the sections and subsections of this Agreement
are for convenience of reference only and are not to be considered in construing this Agreement.

 

2.
The Investment

 

		2.1	On the Effective Date the Company shall issue to the Parent
1,504,152 Ordinary Shares of the Company, of NIS 0.01 par value (the “Shares”), in consideration for an investment
in the Company in an amount equal to the Conversion Amount (the “Investment Amount”).

 

		2.2	The Shares issued to Parent hereunder shall be a fully-paid
and non-assessable shares, free and clear of any liens, encumbrances, pledges, charges, levies, or such other rights to the benefit of
third parties.

 

		2.3	Payment of the Investment Amount by Parent to the Company
shall be done by way of conversion and capitalization of the entire Conversion Amount.

 

		2.4	Upon the issuance of the Shares to the Parent pursuant to
the terms hereof, the entire Conversion Amount shall be deemed as fully discharged and repaid by the Company to the Parent.

 

3.
Miscellaneous

 

		3.1	This Agreement shall be governed by and construed according
to the laws of the State of Israel.

 

		3.2	Any dispute arising under or in relation to this Agreement
shall be resolved in the competent court of Tel-Aviv Jaffa, Israel, to exclude the jurisdiction of any other court.

 

		3.3	Each of the Parties shall take such actions, including the
execution of further instruments, as may be necessary to give full effect to the provisions hereof and to the intent of the Parties hereto.

 

		3.4	No delay or omission to exercise any right, power, or remedy
accruing to any Party upon any breach or default under this Agreement, shall be deemed a waiver of any other breach or default therefore
or thereafter occurring.

 

     

     

    

 

[SIGNATURE PAGE TO LOAN CONVERSION
AGREEMENT]

 

IN WITNESS WHEREOF the Parties have signed this Agreement
as of the date first hereinabove set forth.

 

	/s/ Eden Attias	 
	ParaZero Technologies Ltd.	 
	 	 
	By:	Eden Attias	 
	Title:	Director	 

 

	EXECUTED by Delta Drone	)
	International Ltd (CAN 618 678 701) in	)
	Accordance with section 127(1) of the	)
	Corporations Act 2001	)

  

	/s/ Eden Attias	 	/s/ Christopher Clark
	Signature of Director	 	Signature of Director
	
     

    Eden Attias
	 	
     

    Christopher Clark

	Name of Director	 	Name of Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]